Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. May 15, 2025; 17(5): 105027
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.105027
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.105027
Figure 1 Flowchart illustrating the patient selection process for the study.
PSM: Propensity score matching; IPW: Inverse probability weighting; ICI: Immune checkpoint inhibitor.
- Citation: Wang PJ, Wang J, Yao XM, Cheng WL, Sun L, Yan J, Yu YL, Li SY, Li DP, Jia JH. Evaluation of efficacy and safety of targeted therapy and immune checkpoint inhibitors in metastatic colorectal cancer. World J Gastrointest Oncol 2025; 17(5): 105027
- URL: https://www.wjgnet.com/1948-5204/full/v17/i5/105027.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i5.105027